Thriving at MEDICA 2025!

Saints Sages Surgical Connects the Global New Future of Healthcare

The four-day MEDICA 2025 exhibition has concluded successfully! As a top global event in the medical industry, it witnessed the innovative wave and cooperative consensus of global medical technology. Saints Sages Surgical made a high-profile appearance at Düsseldorf Exhibition Center with its full range of energy device products, demonstrating the technological height and industrial responsibility of "Made in China" on the global stage through its core independent innovation capabilities and international brand vision, and gaining extensive recognition and profound trust from global partners.

Product Strength Wins Global Recognition

The Dual-Energy Fusion Platform SA100, a world's pioneering dual-channel energy device, enables seamless switching between the ultrasonic scalpel module and the advanced bipolar module. It eliminates the need for repeated plugging and unplugging of knife heads to meet diverse intraoperative energy demands. Equipped with RTTE II Real-Time Tissue Adaptive Technology and MPTS Multi-Pulse Tissue Sensing Technology, it has been clinically proven to stably coagulate and occlude 7mm blood vessels, covering surgical procedures in multiple departments such as gastrointestinal surgery and hepatobiliary-pancreatic surgery. Its precision in cutting and safety in vascular coagulation fully comply with the stringent European clinical standards, earning high praise from surgeons and medical institutions in multiple countries.

The SA10 Portable Ultrasonic Soft Tissue Cutting and Hemostasis Device features a highly integrated controller—the world's first portable ultrasonic scalpel controller, as compact as a mobile phone—saving operating room space. It integrates the transducer and knife head into one unit, ensuring the transducer remains in optimal condition with regular use. Powered by the core RTTE II software algorithm, it delivers more precise intraoperative energy output, making surgeries more efficient. With no need for transducer installation and simple operation, it improves the work efficiency of medical staff and has been unanimously praised by surgeons worldwide.

The SP10, the world's first portable advanced bipolar product, has revolutionized the portability of traditional energy devices. Its palm-sized body houses a powerful energy core and MPTS artificial intelligence algorithm, which can adapt to different tissue types, stably complete the coagulation of 7mm large blood vessels, while effectively reducing surgical smoke and tissue adhesion. It significantly lowers procurement costs and expands clinical application scenarios, becoming a hot product sought after by overseas distributors and medical institutions for consultation.

As a source of industry trends and a core hub for cross-border cooperation, MEDICA has built an important bridge for Saints Sages Surgical to connect with the world. During the exhibition, the Saints Sages team conducted efficient communications with distributors, medical institutions, and research partners from Germany, the United States, and other parts of the world through diversified forms such as product hands-on demonstrations, in-depth analysis of clinical cases, and customized solution docking. From negotiations on cutting-edge technology cooperation and docking of clinical application needs, to signing regional agency cooperation agreements and collaborative exploration of research directions, Saints Sages Surgical has won in-depth recognition from global partners with its solid technical accumulation. The exhibition saw a constant flow of visitors for consultation, with numerous prospective partners received and a number of initial cooperation agreements reached, laying a solid foundation for Saints Sages Surgical to expand the global market and build an international cooperation network.

Adhering to the Original Aspiration of Innovation to Empower Global Precision Medicine

This trip to MEDICA not only enabled in-depth dialogue between "Made in China" medical technology and international clinical standards but also vividly practiced the national "15th Five-Year Plan" for the pharmaceutical industry—"tackling core technologies and consolidating industrial advantages". As an innovative enterprise in the field of minimally invasive surgical energy devices, Saints Sages Surgical has always been guided by clinical needs, deeply engaged in independent R&D, dared to innovate, continuously broke through technical bottlenecks, and strived to become a leader in the energy device sector.

In the future, Saints Sages Surgical will take the global clinical needs and industry suggestions collected during the exhibition, continue to increase R&D investment, iterate innovative technologies and products, expand the blueprint for global cooperation, bring the medical technology achievements of "Made in China" into more operating rooms around the world, and contribute Chinese strength to promoting the development of global precision medicine and benefiting more patients.